therapeutics glp 1 activate GLP-1 Drugs: For Multiple Chronic Conditions A clinician's perspective π GLP-1
Description
Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice
Crh, corticotropin-releasing hormone-expressing

Among the plethora of novel agents against diabetes, GLP-1RAs are known to exert various biological effects in extra-pancreatic tissues beyond controlling hyperglycemia (1)

Choose Reference Material", then Unified Preferred Drug List", and then UPDL criteria effective 07.01.2024" from the list of documents